Elena B. Yastrebova
Research Subjects
Elena B. Yastrebova has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Anna Valentinovna Samarina
St. Petersburg Center for the Prevention and Control of AIDS and Infectious Diseases; Pavlov First Saint Petersburg State Medical University
2 shared publications - D. A. Gusev
National Medical Research Center named after V.A. Almazov; Clinical Infectious Diseases Hospital named after S.P. Botkin
2 shared publications A V Gaysina
Center for prevention and control of AIDS and infectious diseases
1 shared publicationA V Samarina
Center for Prevention and Control of AIDS and Infectious Diseases, I. P. Pavlov First State Medical University of St. Petersburg
1 shared publication- A. G. Trishina
Center for the prevention and control of AIDS and infectious diseases
1 shared publication - Dmitriy A. Lioznov
Smorodintsev Research Institute of Influenza, 197022 Saint Petersburg, Russia
1 shared publication
Latest Publications
- Open Access
- 24 June 2025
- Published by SPRIDA in Journal Infectology
- Vol. 17 (2) , 100-106
Socio-Epidemiological and Clinical-Laboratory Characteristics of Patients with HIV and Chronic Hepatitis B+D
The hepatitis B virus (HBV) and the disease it causes have been actively studied for over 50 years. Recent estimates provided by the World Health Organization indicate that approximately 1 in 22 (4.5%) individuals with chronic hepatitis B have antibodies to the hepatitis D virus (HDV). The exact global prevalence of hepatitis D remains unclear due to differences in the sensitivity and specificity of diagnostic tests and the lack of standardized testing systems. In Russia, patients with hepatitis D are not subject to mandatory registration, and the routes of transmission are similar to those of hepatitis B. The disease is often diagnosed at a late stage (e.g., liver cirrhosis) due to the lack of widespread targeted screening for HDV antibodies among HBsAg-positive patients; about two-thirds of patients are unaware of their infection status. The study of socio-epidemiological and clinical-laboratory characteristics of HIV-positive patients co-infected with chronic hepatitis B and delta agent is of significant scientific and practical interest.The aim of this study was to conduct a comparative analysis of socio-epidemiological and clinical-laboratory features of HIV-positive patients with chronic hepatitis B and delta agent compared to patients without HIV infection. Materials and Methods. The study included 50 patients under observation at the city AIDS center, of whom 24 were diagnosed with HIV infection and chronic hepatitis B+D (Group 1), and 26 had chronic hepatitis B+D without HIV infection (Group 2). The mean age of the patients was 46.7±0.5 years, with 34 males (68.0%) and 16 females (32.0%).Results and Discussion. The “social profile” of HIV-positive patients with chronic hepatitis B+D is characterized as follows: these individuals are typically intravenous drug users, lack higher education, are unemployed, not in formal marriages, and have an HIV infection duration of more than 8 years, often with stage 4A HIV infection according to the Russian classification. All patients in this group were receiving antiretroviral therapy, and the vast majority were also on antiviral therapy for chronic hepatitis. Conclusion. Thus, HIV-positive patients with chronic hepatitis B+D significantly differ from those with chronic hepatitis B+D alone in terms of infection routes, education level, marital status, disease duration, aminotransferase levels, and hematological abnormalities. In both groups, severe liver fibrosis (F3-F4) predominated, accounting for a total of 70%. Antiviral therapy for chronic hepatitis B+D using bulevirtide represents a promising direction for the elimination of HBV and HDV and requires further study and analysis.
- 24 June 2025
- Published by SPRIDA in Journal Infectology
- Vol. 17 (2) , 100-106
Open AccessSocio-Epidemiological and Clinical-Laboratory Characteristics of Patients with HIV and Chronic Hepatitis B+D
The hepatitis B virus (HBV) and the disease it causes have been actively studied for over 50 years. Recent estimates provided by the World Health Organization indicate that approximately 1 in 22 (4.5%) individuals with chronic hepatitis B have antibodies to the hepatitis D virus (HDV). The exact global prevalence of hepatitis D remains unclear due to differences in the sensitivity and specificity of diagnostic tests and the lack of standardized testing systems. In Russia, patients with hepatitis D are not subject to mandatory registration, and the routes of transmission are similar to those of hepatitis B. The disease is often diagnosed at a late stage (e.g., liver cirrhosis) due to the lack of widespread targeted screening for HDV antibodies among HBsAg-positive patients; about two-thirds of patients are unaware of their infection status. The study of socio-epidemiological and clinical-laboratory characteristics of HIV-positive patients co-infected with chronic hepatitis B and delta agent is of significant scientific and practical interest.The aim of this study was to conduct a comparative analysis of socio-epidemiological and clinical-laboratory features of HIV-positive patients with chronic hepatitis B and delta agent compared to patients without HIV infection. Materials and Methods. The study included 50 patients under observation at the city AIDS center, of whom 24 were diagnosed with HIV infection and chronic hepatitis B+D (Group 1), and 26 had chronic hepatitis B+D without HIV infection (Group 2). The mean age of the patients was 46.7±0.5 years, with 34 males (68.0%) and 16 females (32.0%).Results and Discussion. The “social profile” of HIV-positive patients with chronic hepatitis B+D is characterized as follows: these individuals are typically intravenous drug users, lack higher education, are unemployed, not in formal marriages, and have an HIV infection duration of more than 8 years, often with stage 4A HIV infection according to the Russian classification. All patients in this group were receiving antiretroviral therapy, and the vast majority were also on antiviral therapy for chronic hepatitis. Conclusion. Thus, HIV-positive patients with chronic hepatitis B+D significantly differ from those with chronic hepatitis B+D alone in terms of infection routes, education level, marital status, disease duration, aminotransferase levels, and hematological abnormalities. In both groups, severe liver fibrosis (F3-F4) predominated, accounting for a total of 70%. Antiviral therapy for chronic hepatitis B+D using bulevirtide represents a promising direction for the elimination of HBV and HDV and requires further study and analysis.
- Open Access
- 24 October 2023
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 13 (4) , 787-796
The 35th anniversary of the North-Western District center for AIDS prevention and control at the Saint Petersburg Pasteur Institute
The organization of the North-Western District Center for AIDS Prevention and Control (AIDS Center) originates from the onset of the HIV epidemic in the Russian Federation. Over the 35 years of work, the staff of the AIDS Center has made an invaluable contribution to the development of HIV diagnostics, the introduction of new clinical and preventive technologies, patient counseling, and training of qualified personnel. The anniversary article highlights the main stages regarding establishment of the AIDS Center as a structural unit of the Saint Petersburg Pasteur Research Institute. The versatile naturally multidisciplinary functions and tasks related to the AIDS Center organization, its major Russia-wide and global achievements are considered. Special attention is paid to the long-term international cooperation, the results of diverse implemented programs and projects supported by the World Health Organization (WHO) as well as the Joint United Nations Programme on HIV/AIDS. The AIDS Center continues to cooperate with the main scientific facilities such as the Pavlov First Saint Petersburg State Medical University, Institute of Experimental Medicine, N.P. Bekhtereva Institute of the Human Brain of the Russian Academy of Sciences, etc. The ongoing joint research invariably contributes to assessing the epidemiology and clinical course of various viral infections and comorbid conditions. The knowledge acquired becomes regularly summarized and published in a series of monographs, journal articles being presented demonstrated at conferences of various levels. Currently, the AIDS Center is represented by several structural divisions continuing to conduct practical and scientific activities on investigating HIV and viral hepatitis.
- 24 October 2023
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 13 (4) , 787-796
Open AccessThe 35th anniversary of the North-Western District center for AIDS prevention and control at the Saint Petersburg Pasteur Institute
The organization of the North-Western District Center for AIDS Prevention and Control (AIDS Center) originates from the onset of the HIV epidemic in the Russian Federation. Over the 35 years of work, the staff of the AIDS Center has made an invaluable contribution to the development of HIV diagnostics, the introduction of new clinical and preventive technologies, patient counseling, and training of qualified personnel. The anniversary article highlights the main stages regarding establishment of the AIDS Center as a structural unit of the Saint Petersburg Pasteur Research Institute. The versatile naturally multidisciplinary functions and tasks related to the AIDS Center organization, its major Russia-wide and global achievements are considered. Special attention is paid to the long-term international cooperation, the results of diverse implemented programs and projects supported by the World Health Organization (WHO) as well as the Joint United Nations Programme on HIV/AIDS. The AIDS Center continues to cooperate with the main scientific facilities such as the Pavlov First Saint Petersburg State Medical University, Institute of Experimental Medicine, N.P. Bekhtereva Institute of the Human Brain of the Russian Academy of Sciences, etc. The ongoing joint research invariably contributes to assessing the epidemiology and clinical course of various viral infections and comorbid conditions. The knowledge acquired becomes regularly summarized and published in a series of monographs, journal articles being presented demonstrated at conferences of various levels. Currently, the AIDS Center is represented by several structural divisions continuing to conduct practical and scientific activities on investigating HIV and viral hepatitis.
- Open Access
- 21 October 2023
- Published by Baltic Medical Education Center in HIV Infection and Immunosuppressive Disorders
- Vol. 15 (3) , 15-25
Current characteristics of the HIV/syphilis co-infection epidemic
Syphilis, alongside with HIV infection, remains a pressing public health issue due to its widespread prevalence among high-risk groups: men who have sex with men (MSM), transgender women, and female sex workers (FSW). The MSM group shows a disproportionately high prevalence rate of HIV infection, with cases of syphilis/HIV co-infection also on the rise in this population. The increase in these co-infection cases deserves special attention. According to the literature, the rate of HIV infection among syphilis patients averages 15.7%. In addition, it varies significantly, going from 3% in the general population to 90% among MSM. Epidemiological surveillance data showed an increase in cases of HIV/syphilis co-infection in the MSM group, with the proportion of co-infection patients varying from 30 to 60% depending on the region. This syndemia can be explained by the fact that syphilis can contribute to HIV transmission and acquisition. The risk of HIV infection is 2 to 5 times higher among people with syphilis. At the same time, STDs are more and more difficult to control as the Internet and dating applications have made it easier to find potential sex partners. Given the high prevalence rate of syphilis among MSM, screening, diagnosis and treatment of STDs in this population should be a health care priority. Early detection and timely treatment of these socially significant diseases play an important role in epidemic prevention measures.
- 21 October 2023
- Published by Baltic Medical Education Center in HIV Infection and Immunosuppressive Disorders
- Vol. 15 (3) , 15-25
Open AccessCurrent characteristics of the HIV/syphilis co-infection epidemic
Syphilis, alongside with HIV infection, remains a pressing public health issue due to its widespread prevalence among high-risk groups: men who have sex with men (MSM), transgender women, and female sex workers (FSW). The MSM group shows a disproportionately high prevalence rate of HIV infection, with cases of syphilis/HIV co-infection also on the rise in this population. The increase in these co-infection cases deserves special attention. According to the literature, the rate of HIV infection among syphilis patients averages 15.7%. In addition, it varies significantly, going from 3% in the general population to 90% among MSM. Epidemiological surveillance data showed an increase in cases of HIV/syphilis co-infection in the MSM group, with the proportion of co-infection patients varying from 30 to 60% depending on the region. This syndemia can be explained by the fact that syphilis can contribute to HIV transmission and acquisition. The risk of HIV infection is 2 to 5 times higher among people with syphilis. At the same time, STDs are more and more difficult to control as the Internet and dating applications have made it easier to find potential sex partners. Given the high prevalence rate of syphilis among MSM, screening, diagnosis and treatment of STDs in this population should be a health care priority. Early detection and timely treatment of these socially significant diseases play an important role in epidemic prevention measures.
- Open Access
- 9 October 2019
- Published by SPRIDA in Journal Infectology
- Vol. 11 (3) , 63-68
Lipid abnormality correction by integrase inhibitor among children taking ARt
Goal. To estimate a possibility of correction laboratory abnormalities (increased level of cholesterol and/or triglycerides at blood of HIV-positive children) by switch the boosted PI on HIV integrase inhibitor (Raltegravir). Methods. The retrospective study was conducted in group of 58 HIV-positive children (less 18 yo). Inclusion criteria were increasing level of cholesterol in blood (more than 5,0 mmol/l) and/or the triglyceride (more than 2,3 mmol/l) ART with boosted PI. The ART regime was changed for all children (n=58). Boosted PI was replaced to integrase inhibitor (RAL). RAL formulation (chewable tablets, 25mg and 100mg) used accordingly weight. Time horizon of observation and laboratory control after boosted PI switch was 24 months. Results. Lab abnormalities in study group (n=58) after switch to RAL were changed: reliable decrease in level of cholesterol (p <0,01), triglycerides (p <0,001), viral load (p <0,001) and growth CD4 count (p <0,05). Conclusion. Boosted PI switch to integrase inhibitor is providing long-term and effective HIV management and improvement of lipid abnormalities among children.
- 9 October 2019
- Published by SPRIDA in Journal Infectology
- Vol. 11 (3) , 63-68
Open AccessLipid abnormality correction by integrase inhibitor among children taking ARt
Goal. To estimate a possibility of correction laboratory abnormalities (increased level of cholesterol and/or triglycerides at blood of HIV-positive children) by switch the boosted PI on HIV integrase inhibitor (Raltegravir). Methods. The retrospective study was conducted in group of 58 HIV-positive children (less 18 yo). Inclusion criteria were increasing level of cholesterol in blood (more than 5,0 mmol/l) and/or the triglyceride (more than 2,3 mmol/l) ART with boosted PI. The ART regime was changed for all children (n=58). Boosted PI was replaced to integrase inhibitor (RAL). RAL formulation (chewable tablets, 25mg and 100mg) used accordingly weight. Time horizon of observation and laboratory control after boosted PI switch was 24 months. Results. Lab abnormalities in study group (n=58) after switch to RAL were changed: reliable decrease in level of cholesterol (p <0,01), triglycerides (p <0,001), viral load (p <0,001) and growth CD4 count (p <0,05). Conclusion. Boosted PI switch to integrase inhibitor is providing long-term and effective HIV management and improvement of lipid abnormalities among children.
- Open Access
- 30 March 2019
- Published by SPRIDA in Journal Infectology
- Vol. 11 (1) , 58-64
CURRENT STATE OF PREVENTION OF MOTHER-TO-CHILD HIV TRANSMISSION IN SAINT-PETERSBURG
Санкт-Петербург занимает лидирующие позиции в оказании помощи ВИЧ-инфицированным беременным женщинам и их детям. Совместные усилия специалистов Центра СПИД, женских консультаций, родовспомогательных учреждений обеспечивают низкую часто- ту перинатальной передачи ВИЧ (1,3% в 2017 г.). В статье отмечены успехи и некоторые проблемы в оказании помощи ВИЧ-инфицированным беременным женщинам, анализ которых будет способствовать улучшению организации помощи при беременности, повышению приверженности к наблюдению и профилактике, дальнейшему снижению числа детей с перинатальным путем заражения.
- 30 March 2019
- Published by SPRIDA in Journal Infectology
- Vol. 11 (1) , 58-64
Open AccessCURRENT STATE OF PREVENTION OF MOTHER-TO-CHILD HIV TRANSMISSION IN SAINT-PETERSBURG
Санкт-Петербург занимает лидирующие позиции в оказании помощи ВИЧ-инфицированным беременным женщинам и их детям. Совместные усилия специалистов Центра СПИД, женских консультаций, родовспомогательных учреждений обеспечивают низкую часто- ту перинатальной передачи ВИЧ (1,3% в 2017 г.). В статье отмечены успехи и некоторые проблемы в оказании помощи ВИЧ-инфицированным беременным женщинам, анализ которых будет способствовать улучшению организации помощи при беременности, повышению приверженности к наблюдению и профилактике, дальнейшему снижению числа детей с перинатальным путем заражения.
- Open Access
- 15 February 2017
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 8 (1) , 50-54
Effective of antiviral therapy of HIV infection and intercurrent diseases in children
The study included 366 HIV-infected children (under-23) and 350 children with perinatal contact with HIV infection (R-75), consisting on the dispensary account in the Department of motherhood and childhood of the Saint Petersburg city AIDS center. The vast majority of children with perinatal HIV receive HAART (95.0%) with high efficacy (undetectable viral load, normalization of CD4 lymphocytes, the absence of clinical manifestations). In the structure of opportunistic viral infections (herpes, respiratory infections) 40.0%, bacterial (bronchitis, tonsillitis, pyoderma, pulmonary tuberculosis) - 28.6%, fungal infections (candidiasis mucous membranes of the oral cavity) and Pneumocystis pneumonia - 31.4%. Complex therapy (etiotropic, pathogenetic, symptomatic) acute respiratory viral infections in children with B-23 and R-75, allows us to achieve in the early stages (6 days treatment) of the regression of the main symptoms of acute respiratory diseases.
- 15 February 2017
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 8 (1) , 50-54
Open AccessEffective of antiviral therapy of HIV infection and intercurrent diseases in children
The study included 366 HIV-infected children (under-23) and 350 children with perinatal contact with HIV infection (R-75), consisting on the dispensary account in the Department of motherhood and childhood of the Saint Petersburg city AIDS center. The vast majority of children with perinatal HIV receive HAART (95.0%) with high efficacy (undetectable viral load, normalization of CD4 lymphocytes, the absence of clinical manifestations). In the structure of opportunistic viral infections (herpes, respiratory infections) 40.0%, bacterial (bronchitis, tonsillitis, pyoderma, pulmonary tuberculosis) - 28.6%, fungal infections (candidiasis mucous membranes of the oral cavity) and Pneumocystis pneumonia - 31.4%. Complex therapy (etiotropic, pathogenetic, symptomatic) acute respiratory viral infections in children with B-23 and R-75, allows us to achieve in the early stages (6 days treatment) of the regression of the main symptoms of acute respiratory diseases.
- Open Access
- 1 January 2016
- Published by Baltic Medical Education Center in HIV Infection and Immunosuppressive Disorders
- Vol. 8 (2) , 39-46
ANALYSIS OF CLINICAL, ANAMNESTIC AND IMMUNOLOGICAL CHARACTERISTICS OF WOMEN OF REPRODUCTIVE AGES HAVING HIV INFECTION AND CHRONIC VIRAL HEPATITIS C
Проведен анализ социально-эпидемиологического, соматического анамнеза и показателей иммунного статуса у 90 женщин репродуктивного возраста при ВИЧ-инфекции и коинфекции ВИЧ и ХВГС. В половине случаев женщины имели среднее образование и были замужем,2/3 от общего числа исследуемых пациенток работали, 34,5% имели детей, у 41,1% регистрировалась соматическая патология с преобладанием болезней мочевыделительной системы. При оценке результатов социально-эпидемиологического и демографического анамнеза не выявлено существенных различий в исследуемых группах, за исключением преобладания в группах женщин с ВИЧ и ХВГС употребления внутривенных наркотиков (96,7 и 93,3%) и уголовных правонарушений (16,7 и 13,3%). У женщин с ВИЧ-инфекцией с ХВГС без лечения установлены низкие показатели СD4-лимфоцитов в крови (менее 350 клеток/мкл) как в начале исследования, так и в динамике наблюдения через 12 месяцев на фоне ВААРТ, что свидетельствует о более медленном темпе восстановления иммунитета в связи с опосредованным действием вируса гепатита С на СD4-лимфоциты в крови.
- 1 January 2016
- Published by Baltic Medical Education Center in HIV Infection and Immunosuppressive Disorders
- Vol. 8 (2) , 39-46
Open AccessANALYSIS OF CLINICAL, ANAMNESTIC AND IMMUNOLOGICAL CHARACTERISTICS OF WOMEN OF REPRODUCTIVE AGES HAVING HIV INFECTION AND CHRONIC VIRAL HEPATITIS C
Проведен анализ социально-эпидемиологического, соматического анамнеза и показателей иммунного статуса у 90 женщин репродуктивного возраста при ВИЧ-инфекции и коинфекции ВИЧ и ХВГС. В половине случаев женщины имели среднее образование и были замужем,2/3 от общего числа исследуемых пациенток работали, 34,5% имели детей, у 41,1% регистрировалась соматическая патология с преобладанием болезней мочевыделительной системы. При оценке результатов социально-эпидемиологического и демографического анамнеза не выявлено существенных различий в исследуемых группах, за исключением преобладания в группах женщин с ВИЧ и ХВГС употребления внутривенных наркотиков (96,7 и 93,3%) и уголовных правонарушений (16,7 и 13,3%). У женщин с ВИЧ-инфекцией с ХВГС без лечения установлены низкие показатели СD4-лимфоцитов в крови (менее 350 клеток/мкл) как в начале исследования, так и в динамике наблюдения через 12 месяцев на фоне ВААРТ, что свидетельствует о более медленном темпе восстановления иммунитета в связи с опосредованным действием вируса гепатита С на СD4-лимфоциты в крови.
- Open Access
- 15 September 2015
- Published by ECO-Vector LLC in Medical academic journal
- Vol. 15 (3) , 45-54
THE MENTAL DEVELOPMENT OF HIV-INFECTED CHILDREN
A clinical laboratory and neuropsychological study included 74 HIV-infected children under dispensary follow-up at the Department of Maternity and Childhood of Saint-Petersburg AIDS Center. The mental development of most HIV-infected children was found to be delayed. HIV progression was associated with disturbed kinesthesia and with difficulties in self-control. Pronounced immunosuppression hampers the development of interhemispheric relationships, voluntary visual perception, and visual memorization, and causes difficulties in recollecting of familiar images. High blood HIV RNA is associated with impaired voluntary visual perception in preschool children and with difficulties in memorizing of logical information in schoolchildren. HAART improves children s attention, ameliorates fatigue, and facilitates long-term concentration.
- 15 September 2015
- Published by ECO-Vector LLC in Medical academic journal
- Vol. 15 (3) , 45-54
Open AccessTHE MENTAL DEVELOPMENT OF HIV-INFECTED CHILDREN
A clinical laboratory and neuropsychological study included 74 HIV-infected children under dispensary follow-up at the Department of Maternity and Childhood of Saint-Petersburg AIDS Center. The mental development of most HIV-infected children was found to be delayed. HIV progression was associated with disturbed kinesthesia and with difficulties in self-control. Pronounced immunosuppression hampers the development of interhemispheric relationships, voluntary visual perception, and visual memorization, and causes difficulties in recollecting of familiar images. High blood HIV RNA is associated with impaired voluntary visual perception in preschool children and with difficulties in memorizing of logical information in schoolchildren. HAART improves children s attention, ameliorates fatigue, and facilitates long-term concentration.